Gene sequence construct for gene therapy of human immunodeficiency virus infection
US-2024352096-A1 · Oct 24, 2024 · US
RNA viruses
RNA viruses · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/10 |
| Official title | RNA viruses |
| Display label | RNA viruses |
| Total patents | 823 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 22 |
| 2016 | 32 |
| 2017 | 50 |
| 2018 | 75 |
| 2019 | 80 |
| 2020 | 81 |
| 2021 | 99 |
| 2022 | 79 |
| 2023 | 127 |
| 2024 | 107 |
| 2025 | 59 |
| 2026 | 12 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Characterization of potent and broadly neutralizing monoclonal antibodies against sars-cov-2, its variants, and related coronaviruses and methods of use
US-2024343781-A1 · Oct 17, 2024 · US
Multivalent anti-SARS-CoV-2 nanobodies
US-12098186-B1 · Sep 24, 2024 · US
Norovirus immunoassay method and immunoassay instrument
US-2024248085-A1 · Jul 25, 2024 · US
Compositions and methods related to viral vaccines
US-2017348409-A1 · Dec 7, 2017 · US
Antibodies that neutralize rsv, mpv and pvm and uses thereof
US-2017121393-A1 · May 4, 2017 · US
Antibodies that neutralize RSV, MPV and PVM and uses thereof
US-9498531-B2 · Nov 22, 2016 · US
Anti-dengue virus antibodies and uses thereof
US-9499607-B2 · Nov 22, 2016 · US
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
US-9493549-B2 · Nov 15, 2016 · US
Recombinant production of mixtures of antibodies
US-2016319320-A1 · Nov 3, 2016 · US
Piscine reovirus immunogenic compositions
US-2016287694-A1 · Oct 6, 2016 · US
Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
US-9457074-B2 · Oct 4, 2016 · US
Viral Vaccine Vectors
US-2016279229-A9 · Sep 29, 2016 · US
Method for improving antibody stability
US-2016275238-A1 · Sep 22, 2016 · US
Production of recombinant proteins with simple glycoforms
US-2016272696-A1 · Sep 22, 2016 · US
Rotavirus subunit vaccines and methods of making and use thereof
US-9446117-B2 · Sep 20, 2016 · US
Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (mers-cov) and engineered bispecific fusions with inhibitory peptides
US-2016264647-A1 · Sep 15, 2016 · US
Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
US-9428554-B2 · Aug 30, 2016 · US
Human Antibodies to Ebola Virus Glycoprotein
US-2016215040-A1 · Jul 28, 2016 · US
IMMUNOGENIC MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) COMPOSITIONS AND METHODS
US-2016206729-A1 · Jul 21, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/10?
- CPC C07K16/10 is the Cooperative Patent Classification code for “RNA viruses.”
- How many patents are filed under CPC C07K16/10 (RNA viruses)?
- Our database includes 823 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/10 growing?
- Publication counts under this code: 107 in 2024 vs 59 in 2025 (latest complete years).